TLR-28244-50714
2 vaccinations
3 coded responses
17 check-ins
2 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 209 / MD
- Registered
- 2022-06-23
- Relationship
- Child or adolescent in my care
- Guardian
- XFK-11704-38165
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-22
Dose 1 — Moderna
-
2022-06-23
Registered in v-safe
- 2022-06-24
- 2022-06-25
-
2022-06-26
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Good · Irritability/cryingUnder 3 check-in
-
2022-06-27
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Good · Fever · Irritability/cryingUnder 3 check-in
-
2022-06-28
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Fair · Fever · Sleepiness, Irritability/cryingUnder 3 check-in
-
2022-06-29
Health check-in — day 7, dose 1, under 3Feeling: Fair · Fever · Sleepiness, Irritability/crying · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationUnder 3 check-in
-
2022-06-29
Report sent to call center — day 7, dose 1, under 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-06-30
- 2022-07-06
-
2022-07-06
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-07-22
Dose 2 — Moderna
- 2022-07-22
-
2022-07-27
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Good · Irritability/cryingUnder 3 check-in
- 2022-07-28
- 2022-07-29
-
2022-08-05
Survey response — day 14, dose 2, under 3MedDRA: Drooling, Rash — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Drool rashMedDRA releases: 2024-11 · check-in free text available
-
2022-08-05
Report sent to call center — day 14, dose 2, under 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-08-08
- 2022-08-08
- 2022-08-19
-
2022-08-26
Survey response — day 35, dose 2, under 3MedDRA: Nasal congestion — Feeling: GoodFree text: Stuffy nose, probably from her brothers daycare illness last weekMedDRA releases: 2024-11 · check-in free text available
- 2022-09-04
- 2022-10-21
-
2023-01-20
Survey response — 6 months, dose 2, under 3MedDRA: Cough, Rhinorrhoea — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-22 | Moderna | No |
| 2 | 2022-07-22 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-06-29 | Successful 2022-07-06 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
| 2022-08-05 | Unsuccessful |
Free text
Release 12 (Under 3) — day 14, dose 2, under 3
Symptoms: Drool rash
Release 12 (Under 3) — day 35, dose 2, under 3
Symptoms: Stuffy nose, probably from her brothers daycare illness last week
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Drooling | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Rash | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release